| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 5.00 | | | | | $ | 43,500,000 | | |
Underwriting discount
|
| | | $ | 0.30 | | | | | $ | 1,557,085 | | |
Proceeds, before expenses, to us, as adjusted for sales to THP, PSC and certain of our directors, executive officers and other insiders(1)
|
| | | $ | 4.70 | | | | | $ | 41,942,915 | | |
| Morgan Stanley | | |
Piper Sandler
|
|
| | |
Page
|
| |||
Prospectus Supplement | | | | | | | |
| | | | S-ii | | | |
| | | | S-iii | | | |
| | | | S-1 | | | |
| | | | S-5 | | | |
| | | | S-7 | | | |
| | | | S-9 | | | |
| | | | S-13 | | | |
| | | | S-22 | | | |
| | | | S-22 | | | |
| | | | S-22 | | | |
| | | | S-23 | | |
| Prospectus | | | | | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 14 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 29 | | |
|
Public offering price per share
|
| | | | | | | | | $ | 5.00 | | |
|
Net tangible book value per share as of March 31, 2023
|
| | | $ | 0.11 | | | | | | | | |
|
Increase in net tangible book value per share attributable to the offering
|
| | | | 0.86 | | | | | | | | |
|
As-adjusted net tangible book value per share after this offering
|
| | | | | | | | | | 0.97 | | |
|
Dilution per share to new investors
|
| | | | | | | | | $ | 4.03 | | |
Name
|
| |
Number of Shares
|
| |||
Morgan Stanley & Co. LLC
|
| | | | 5,655,000 | | |
Piper Sandler & Co.
|
| | | | 3,045,000 | | |
Total:
|
| | | | 8,700,000 | | |
| | | | | | | | |
Total
|
| |||||||||
| | |
Per
Share |
| |
No
Exercise |
| |
Full
Exercise |
| |||||||||
Public offering price
|
| | | $ | 5.00 | | | | | $ | 43,500,000 | | | | | $ | 50,025,000 | | |
Underwriting discounts and commissions to be paid by us(1):
|
| | | $ | 0.30 | | | | | $ | 1,557,085 | | | | | $ | 1,948,585 | | |
Proceeds, before expenses, to us, as adjusted for sales to THP, PSC and certain of our directors, executive officers and other insiders(1):
|
| | | $ | 4.70 | | | | | $ | 41,942,915 | | | | | $ | 48,076,415 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 14 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 28 | | | |
| | | | | 29 | | |
.U6C,IQ*4.+0E:7$I40'$:A*@#VC< =#
MZP#71,PU?+CR I5I
M[2JWNU<:,Z3LRQS/T>.*BW>'(S:X+NVW_P#);B,(C;M#U\$K4K37N\6L_P!R
M^A9[8O<=\J?F!XPY VSS<,\62^-(-S-SF-2KG=5LEU,;<6&VXPA0%>>:/*G;.;,O&67W*YT(,Q6H,*WQV&5-,,M:J.A4=25+6M9
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M=-/Z^(SUK0TA3CB@AM *EK40$A(&I))[ *XB4GUS:2ED!G
(L*\MT.[0[IROR7&N"6W4*1
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3MV:::US',\32CL5X>A0!0'__V0$!
end